Contingent Use of Fetal Fibronectin Testing and Cervical Length Measurement in Women With Preterm Labour

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 4, 2010, Pages 307-312

  Audibert, François ^a   Fortin, Suzanne ^a   Delvin, Edgard ^a   Djemli, Anissa ^a   Brunet, Suzanne ^a   Dubé, Johanne ^a   Fraser, William D ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cervical length; Fetal fibronectin; IGFBP 1; Preterm labour

Indexed keywords

FIBRONECTIN; SOMATOMEDIN BINDING PROTEIN 1; IGFBP1 PROTEIN, HUMAN;

ADULT; ARTICLE; BODILY SECRETIONS; CERVICAL LENGTH MEASUREMENT; CERVICOVAGINAL SECRETION; CONTINGENT USE; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FETAL FIBRONECTIN TESTING; FUNCTION TEST; GESTATIONAL AGE; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PREMATURE LABOR; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; METABOLISM; PHOSPHORYLATION; PREDICTION AND FORECASTING; PREGNANCY; PREMATURITY; PROSPECTIVE STUDY; UTERINE CERVIX; UTERINE CERVIX MUCUS; VALIDATION STUDY;

ADULT; CERVIX MUCUS; CERVIX UTERI; FEMALE; FIBRONECTINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; OBSTETRIC LABOR, PREMATURE; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77954904166     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34473-5     Document Type: Article

References (31)

1. Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet 2008, 371(9606):75-84.
2. Iams J.D., Romero R., Culhane J.F., Goldenberg R.L. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008, 371(9607):164-175.
3. Iams J.D. Prediction and early detection of preterm labor. Obstet Gynecol 2003, 101:402-412.
4. Leitich H., Egarter C., Kaider A., Hohlagschwandtner M., Berghammer P., Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol 1999, 180:1169-1176.
5. Goldenberg R.L., Mercer B.M., Iams J.D., Moawad A.H., Meis P.J., Das A., et al. The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1997, 177:8-12.
6. Lockwood C.J., Senyei A.E., Dische M.R., Casal D., Shah K.D., Thung S.N., et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991, 325:669-674.
7. Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev 2008:CD006843.
8. Iams J.D., Goldenberg R.L., Meis P.J., Mercer B.M., Moawad A., Das A., et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Network. N Engl J Med 1996, 334:567-572.
9. Coleman M.A., Keelan J.A., McCowan L.M., Townend K.M., Mitchell M.D. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1beta, IL-6 and IL-8 with fetal fibronectin and cervical dilatation. Eur Obstet Gynecol Reprod Biol 2001, 95:154-158.
10. Owen J., Yost N., Berghella V., Thom E., Swain M., Dildy G.A., et al. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 2001, 286:1340-1348.
11. Berghella V., Roman A., Daskalakis C., Ness A., Baxter J.K. Gestational age at cervical length measurement and incidence of preterm birth. Obstet Gynecol 2007, 110(2 Pt 1):311-317.
12. Grimes-Dennis J., Berghella V. Cervical length and prediction of preterm delivery. Curr Opin Obstet Gynecol 2007, 19:191-195.
13. Crane J.M., Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol 2008, 31:579-587.
14. Schmitz T., Kayem G., Maillard F., Lebret M.T., Cabrol D., Goffinet F. Selective use of sonographic cervical length measurement for predicting imminent preterm delivery in women with preterm labor and intact membranes. Ultrasound Obstet Gynecol 2008, 31:421-426.
15. Rizzo G., Capponi A., Arduini D., Lorido C., Romanini C. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996, 175(5):1146-1151.
16. Rozenberg P., Goffinet F., Malagrida L., Giudicelli Y., Perdu M., Houssin I., et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1997, 176(1 Pt 1):196-199.
17. Goldenberg R.L., Iams J.D., Das A., Mercer B.M., Meis P.J., Moawad A.H., et al. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Feta Medicine Units Network. Am J Obstet Gynecol 2000, 182:636-643.
18. Hincz P., Wilczynski J., Kozarzewski M., Szaflik K. Two-step test: the combined use of fetal fibronectin and sonographic examination of the uterine cervix for prediction of preterm delivery in symptomatic patients. Acta Obstet Gynecol Scand 2002, 81:58-63.
19. Gomez R., Romero R., Medina L., Nien J.K., Chaiworapongsa T., Carstens M., et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 2005, 192:350-359.
20. Schmitz T., Maillard F., Bessard-Bacquaert S., Kayem G., Fulla Y., Cabrol D., et al. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol 2006, 194:138-143.
21. Paternoster D.M., Muresan D., Vitulo A., Serena A., Battagliarin G., Dell'avanzo M., et al. Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery. Acta Obstet Gynecol Scand 2007, 86:151-155.
22. Elizur S.E., Yinon Y., Epstein G.S., Seidman D.S., SchiffE., Sivan E. Insulin-like growth factor binding protein-1 detection in preterm labor: evaluation of a bedside test. Am J Perinatol 2005, 22:305-309.
23. Kurkinen-Raty M., Ruokonen A., Vuopala S., Koskela M., Rutanen E.M., Karkkainen T., et al. Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth. BJOG 2001, 108:875-881.
24. Kekki M., Kurki T., Karkkainen T., Hiilesmaa V., Paavonen J., Rutanen E.M. Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 2001, 80:546-551.
25. Berghella V., Bega G., Tolosa J.E., Berghella M. Ultrasound assessment of the cervix. Clin Obstet Gynecol 2003, 46:947-962.
26. Berghella V., Talucci M., Desai A. Does transvaginal sonographic measurement of cervical length before 14 weeks predict preterm delivery in high-risk pregnancies?. Ultrasound Obstet Gynecol 2003, 21:140-144.
27. Abenhaim H.A., Morin L., Benjamin A. Does availability of fetal fibronectin testing in the management of threatened preterm labour affect the utilization of hospital resources?. J Obstet Gynaecol Can 2005, 27:689-694.
28. Tanir H.M., Sener T., Yildiz Z. Cervical phosphorylated insulin-like growth factor binding protein-1 for the prediction of preterm delivery in symptomatic cases with intact membranes. J Obstet Gynaecol Res 2009, 35:66-72.
29. Altinkaya O., Gungor T., Ozat M., Danisman N., Mollamahmutoglu L. Cervical phosphorylated insulin-like growth factor binding protein-1 in prediction of preterm delivery. Arch Gynecol Obstet 2009, 279:279-283.
30. Balic D., Latifagic A., Hudic I. Insulin-like growth factor-binding protein-1 (IGFBP-1) in cervical secretions as a predictor of preterm delivery. J Matern Fetal Neonatal Med 2008, 21:297-300.
31. Sridharan L., Greenland P. Editorial policies and publication bias: the importance of negative studies. Arch Intern Med 2009, 169:1022-1023.